|Adult ADHD Home||Succeed at Work||ADHD Self Test|
|Love & Friendships||Manage Time & Money||ADHD Adult Blogs|
|The Organized Life||Stress, Sleep, Health||Adult Support Groups|
|Apps & Gadgets||Inspirational Stories||Expert Answers|
|ADHD Parenting Home||Schedules & Time||Sample Routines|
|Discipline & Behavior||Teens & Young Adults||Parent Support Group|
|ADHD Parenting Skills||Nutrition & Diet||Parenting Blogs|
|Friendships & Social Skills||Sports & Hobbies||Summer & Camps|
|ADHD Treatment Home||ADHD Medications||Medication Reviews||Adderall|
|Treating Your Child||Nutrition & Diet||Fish Oil Printable||Daytrana|
|Expert Q&As||Non-Medical Treatment||Find Professionals||Strattera|
|Behavior Therapy||Brain Training||Quillivant XR||Vyvanse|
|ADHD/LD School Home||High School & College||Accommodations|
|IEPs & 504s||ADHD Study Skills||ADHD School Guide|
|Working with School||School Organization Help||College Survival Guide|
|Social Skills at School||For Teachers Only||Is it LD? A Self Test|
|ADHD Diagnosis Home||ADHD & Women||Is it ADHD? Self Tests|
|Getting a Diagnosis||Is it a Related Condition?||Medical Q&As|
|ADHD Symptoms||Post Diagnosis Next Steps||Myths & Realities|
|Is it Learning Disabilities?||ADHD Treatment||ADHD Support Groups|
|Tools and Checklists|
|ADHD Topics A-Z|
|Share Your Story|
|Give a Gift|
|Buy Back Issues|
Vyvanse Approved for Adult Use
FDA approves Vyvanse for use in adults.
Sunday May 4th - 4:06pm
Filed Under: Vyvanse
The pharmaceutical company Shire has announced that its stimulant medication, Vyvanse, used to treat attention deficit hyperactivity disorder (ADHD) in children, has now been approved for use by adults.
The approval by the Food and Drug Administration comes after a four-week, placebo-controlled study, in which researchers administered three different dosages — 30 mg, 50 mg, and 70 mg — to more than 400 adults between the ages of 18 and 55. Among their findings, across all doses, the ADHD symptoms experienced by the participants improved between 57 and 61 percent, and such improvements were significantly greater than with a placebo.
The most commonly reported side effects in the study included dry mouth, loss of appetite, and difficulty falling asleep. For more information, read the press release issued by Shire, on April 23, as well as the letter of approval issued by the FDA, earlier that day.